MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Short and long-term Impact of Covid-19 Pandemic on motor and non-motor symptoms in Leucine-rich repeat kinase2 (LRRK2) associated Parkinson’s disease

    A. Nasri, S. Mrabet, Y. Abida, A. Souissi, A. Gharbi, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To determine short and long-term impact of COVID-19 on motor(MS) and non-motor(NMS) symptoms among Tunisian PD patients according to Leucine-rich repeat kinase2 (LRRK2)-carrying status.…
  • 2022 International Congress

    Connectivity matrices for differentiating voluntary stopping states and involuntary freezing states in Parkinson’s disease

    D. Salgado, A. Pineda, C. Alves, R. Carra, F. Rodrigues, M. Souza, R. Cury (São Paulo, Brazil)

    Objective: The present study aims to demonstrate a possible application of the analysis of functional brain connectivity from brain connectivity matrices. Specifically, we aim to: - Differentiate…
  • 2022 International Congress

    Diagnostic accuracy of dopamine SPECT in degenerative parkinsonism compared to neuropathological diagnosis.

    A. Hastings, H. Morris, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: To evaluate diagnostic accuracy of dopamine SPECT against neuropathological diagnosis in a large cohort of patients with parkinsonism. Background: Diagnosis of parkinsonian syndromes remains…
  • 2022 International Congress

    Studying Care Patterns and Support Preferences Among People Living with Parkinson’s Disease

    C. Pearson, M. Feeney, A. Willis, N. Yarab, R. Dolhun, V. Todaro, S. Rosenfeld (Chicago, USA)

    Objective: To understand health care utilization among Medicare beneficiaries living with Parkinson’s Disease (PD) and how care patterns differ across demographic groups. Background: Optimal care…
  • 2022 International Congress

    LRRK2 Inhibition by BIIB122: Trial designs for two efficacy and safety studies in Parkinson’s disease patients with and without LRRK2 mutations (Lighthouse and Luma)

    J. Shirvan, D. Jennings, P. Wang, R. Maciuca, S. Sahu, F. Sedarati, A. Kay, K. Fraser, S. Huntwork-Rodriguez, M. Yang, M. Levee, P. Chin, T. Dam (Cambridge, USA)

    Objective: Describe Luma and Lighthouse, two studies that investigate efficacy and safety of BIIB122, a LRRK2 inhibitor. Background: Increased LRRK2 kinase activity has been linked…
  • 2022 International Congress

    Feasibility of using ENROLL-HD for health services research: Evaluation of delays in Huntington’s Disease (HD) Diagnosis

    A. Mendizabal, S. Perlman, Y. Bordelon (LOS ANGELES, USA)

    Objective: To describe social and structural determinants of health of HD patients and to evaluate the feasibility of using this dataset for health services research.…
  • 2022 International Congress

    GLUT1 Deficiency Syndrome with Novel mutation responsive to GPi DBS

    C. Torres Vásquez, C. Zepeda Salazar, M. Rodriguez Violante, G. Cervantes Arriaga, D. Tristan, V. Cerino, T. Ortegano, A. Abundes Corona (Ciudad de mexico, Mexico)

    Objective: To describe a case of a patient with a progressive primary isolated generalized dystonia of childhood onset associated to a novel SLC2A1 mutation with…
  • 2022 International Congress

    The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

    S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)

    Objective: To analyze the sensitivity and specificity of the clonidine growth hormone (CGH) to distinguish probable multiple system atrophy (MSA) from pure autonomic failure (PAF),…
  • 2022 International Congress

    The Edmond J. Safra Fellowship in Movement Disorders: A Global Network of Parkinson’s Experts

    R. Dolhun (New York, USA)

    Objective: To train more movement disorder clinician-researchers around the world to meet growing care and research needs in Parkinson’s and related disorders. Background: Care from…
  • 2022 International Congress

    Evaluation of Genetic influence of APOE on Clinical and motor functions among Idiopathic Parkinson’s Disease Patients; A comparative study

    W. Ibrahim, H. Shehata, L. Rashed, A. Sabbah, H. Amer (Cairo, Egypt)

    Objective: We studied the effect of APOE ε4 carriers and non-carriers on clinical and motor functions in patients with IPD Background: The significance of APOE…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley